Skip to main content
. Author manuscript; available in PMC: 2014 Feb 11.
Published in final edited form as: Am J Gastroenterol. 2012 Sep;107(9):1283–1287. doi: 10.1038/ajg.2012.59

Table 4.

Among the 159 physicians who knew guideline recommendation for three 5–8 mm hyperplastic polyps, Cochrane Armitage Trend test of differences in predictors between gastroenterologists who follow the guidelines (n=147) vs. deviate from guidelines (n=11) in their clinical practice

Attitude Follow guideline N (%) Deviate from guideline N (%)
Guidelines are a convenient source of advice (p=0.02)
 Agree 142 (97%) 9 (82%)
 Neutral 4 (3%) 0 (0%)
 Disagree 1 (1%) 2 (18%)
Current clinical research justifies recommendations for post-polypectomy intervals (p=0.03)
 Agree 115 (78%) 6 (55%)
 Neutral 24 (16%) 1 (9%)
 Disagree 8 (5.4) 4 (36%)
Colonoscopy guidelines increase the risk of a missed cancer diagnosis (p=0.008)
 Agree 13 (9%) 4 (36%)
 Neutral 29 (20%) 1 (9%)
 Disagree 103 (71%) 6 (55%)
Colonoscopy guidelines do not apply to many of my patients (p=0.02)
 Agree 7 (5%) 2 (18%)
 Neutral 9 (6%) 4 (36%)
 Disagree 131 (89%) 5 (45%)
There are benefits of repeat colonoscopy not captured in the guidelines (p=0.04)
 Agree 52 (35%) 7 (64%)
 Neutral 44 (30%) 2 (18%)
 Disagree 51 (35%) 2 (18%)

Among the 159 physicians, one subject did not respond to self-reported practice for scenario of three 5–8 mm hyperplastic polyps. Range of non-respondents to questions that assessed factors associated with guideline adherence were 1 to 3 gastroenterologists

All physicians who deviated from guidelines chose to survey at shorter intervals than guideline recommendations

Percentages are rounded to nearest whole number